| 國立臺灣大學 |
2015 |
Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
|
Lu, Yen-Shen; Chen, Tom Wei-Wu; Lin, Ching-Hung; Yeh, Dah-Cherng; Tseng, Ling-Ming; Wu, Pei-Fang; Rau, Kun-Ming; Chen, Bang-Bin; Chao, Ta-Chung; Huang, Shu-Min; Huang, Chiun-Sheng; Shih, Tiffany Ting-Fang; Cheng, Ann-Lii; 林志弘; 陳偉武; 盧彥伸; 林璟宏; 施庭芳; 吳佩芳; 鄭安理; 陳邦斌; 黃俊升; 林季宏 |
| 臺大學術典藏 |
2018-09-10T15:18:47Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Tseng, Ling-Ming; ANN-LII CHENG; Tseng, Ling-Ming; Wu, Pei-Fang; Wu, Pei-Fang; Rau, Kun-Ming; Chen, Bang-Bin; Chen, Bang-Bin; Chao, Ta-Chung; Chao, Ta-Chung; Huang, Shu-Min; Huang, Shu-Min; Huang, Chiun-Sheng; Huang, Chiun-Sheng; Shih, Tiffany Ting-Fang; Shih, Tiffany Ting-Fang; Cheng, Ann-Lii; Yeh, Dah-Cherng; CHING-HUNG LIN; Yeh, Dah-Cherng; Lin, Ching-Hung; Lin, Ching-Hung; BANG-BIN CHEN; Chen, Tom Wei-Wu; 林志弘;陳偉武;盧彥伸;林璟宏;施庭芳;吳佩芳;鄭安理;陳邦斌;黃俊升;林季宏; Lu, Yen-Shen;Chen, Tom Wei-Wu;Lin, Ching-Hung;Yeh, Dah-Cherng;Tseng, Ling-Ming;Wu, Pei-Fang;Rau, Kun-Ming;Chen, Bang-Bin;Chao, Ta-Chung;Huang, Shu-Min;Huang, Chiun-Sheng;Shih, Tiffany Ting-Fang;Cheng, Ann-Lii; TIFFANY TING-FANG SHIH; Lu, Yen-Shen; Lu, Yen-Shen; Chen, Tom Wei-Wu; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2015 |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Cheng A.-L.; Shih T.T.-F.; CHIUN-SHENG HUANG; Huang S.-M.; Chao T.-C.; Chen B.-B.; Rau K.-M.; Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Shih T.T.-F; Cheng A.-L; Taiwan Breast Cancer Consortium; Huang C.-S; Huang S.-M; Chao T.-C; Chen B.-B; Rau K.-M; Wu P.-F; Tseng L.-M; Yeh D.-C; Lin C.-H; Chen T.W.-W; YEN-SHEN LU; Taiwan Breast Cancer Consortium;Cheng A.-L;Shih T.T.-F;Huang C.-S;Huang S.-M;Chao T.-C;Chen B.-B;Rau K.-M;Wu P.-F;Tseng L.-M;Yeh D.-C;Lin C.-H;Chen T.W.-W;Yen-Shen Lu |
| 臺大學術典藏 |
2020-08-06T07:51:48Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.;Chen T.W.-W.;Lin C.-H.;Yeh D.-C.;Tseng L.-M.;Wu P.-F.;Rau K.-M.;Chen B.-B.;Chao T.-C.;Huang S.-M.;Huang C.-S.;Tiffany Ting-Fang Shih;Cheng A.-L.;Taiwan Breast Cancer Consortium; Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; TIFFANY TING-FANG SHIH; Cheng A.-L.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2022-03-15T05:39:30Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; WEI-WU CHEN; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; Cheng A.-L.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium |
| 國立臺灣大學 |
2008 |
Bevacizumab Pretreatment and Long-Acting Gas Infusion on Vitreous Clear- up after Diabetic Vitrectomy
|
楊中美; 葉伯廷; 楊長豪; 陳慕師; YANG, CHUNG-MAY; YEH, PO-TING; YANG, CHANG-HAO; CHEN, MUH-SHY |
| 臺大學術典藏 |
2018-09-10T06:48:56Z |
Bevacizumab Pretreatment and Long-acting Gas Infusion on Vitreous Clear-up After Diabetic Vitrectomy
|
Yang, C.-M. and Yeh, P.-T. and Yang, C.-H. and Chen, M.-S.; 楊中美;葉伯廷;楊長豪;陳慕師; Yang, CM;Yeh, PT;Yang, CH;Chen, MS.; YANG, CHUNG-MAY;YEH, PO-TING;YANG, CHANG-HAO;CHEN, MUH-SHY; CHUNG-MAY YANG; Yang, CM; Yeh, PT; CHANG-HAO YANG; PO-TING YEH; Yang, CH; Chen, MS. |
| 臺大學術典藏 |
2022-07-15T06:43:33Z |
Bevacizumab Pretreatment and Long-acting Gas Infusion on Vitreous Clear-up After Diabetic Vitrectomy
|
CHUNG-MAY YANG; Yeh P.-T.; Yang C.-H.; Chen M.-S. |
| 臺大學術典藏 |
2022-07-20T06:34:01Z |
Bevacizumab Pretreatment and Long-acting Gas Infusion on Vitreous Clear-up After Diabetic Vitrectomy
|
Yang C.-M.; PO-TING YEH; Yang C.-H.; Chen M.-S. |
| 國立臺灣大學 |
2008-06 |
Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
|
Yang, CM; Yeh, PT; Yang, CH; Chen, MS. |
| 國立臺灣大學 |
2009 |
Bevacizumab Pretreatment in Vitrectomy with Silicone Oil for Severe Diabetic Retinopathy
|
葉伯廷; 楊中美; 林友祺; 陳慕師; 楊長豪; YEH, PO-TING; YANG, CHUNG-MAY; LIN, YU-CHI; CHEN, MUH-SHY; YANG, CHANG-HAO |
| 臺大學術典藏 |
2022-07-14T07:25:57Z |
Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy
|
Yeh P.-T.; Yang C.-M.; Lin Y.-C.; Chen M.-S.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-15T06:43:28Z |
Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy
|
Yeh P.-T.; CHUNG-MAY YANG; Lin Y.-C.; Chen M.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-07-20T06:34:01Z |
Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy
|
PO-TING YEH; Yang C.-M.; Lin Y.-C.; Chen M.-S.; Yang C.-H. |
| 臺北醫學大學 |
2018-07 |
Bevacizumab Reduces S100A9+ MDSC Linked to Intracranial Control in Patients with EGFR Mutant Lung Adenocarcinoma.
|
馮博皓; Po-Hao Feng, Kuan-Yuan Chen, Yu-Chen Huang, Ching-Shan Luo, Shen Ming Wu, Tzu-Tao Chen, Chun-Nin Lee, Chi-Tai Yeh, Hsiao-Chi Chuang, Chia-Li Han, Chiou-Feng Lin, Wei-Hwa Lee, Chih-Hsi Kuo, Kang-Yun Lee |
| 臺大學術典藏 |
2013 |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU; Cheng A.-L. |
| 國立成功大學 |
2013 |
Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
|
Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii |
| 國立臺灣大學 |
2013 |
Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
|
Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 許駿; 孫家棟 |
| 臺大學術典藏 |
2020-04-10T12:16:09Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Chiun Hsu; Cheng A.-L.; Yang T.-S.; Shun C.-T.; Shao Y.-Y. |
| 臺大學術典藏 |
2021-03-18T02:02:48Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.;Kang Y.K.;Yang T.-S.;Chia-Tung Shun;Shao Y.-Y.;Su W.-C.;Sandoval-Tan J.;Chiou T.-J.;Jin K.;Hsu C.;Cheng A.-L.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:47Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; ANN-LII CHENG |
| 高雄醫學大學 |
2009 |
Bevacizumab在缺血性視神經病變治療的應用 -- 初報
|
吳文權;賴昱宏 |
